Low Solubility Peptide Reconstitution Solution for Injection, all strengths and presentations, Ge...
FDA Drug Recall #D-0076-2026 — Class II — July 30, 2025
Recall Summary
| Recall Number | D-0076-2026 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 30, 2025 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | GenoGenix LLC |
| Location | Boca Raton, FL |
| Product Type | Drugs |
Product Description
Low Solubility Peptide Reconstitution Solution for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.Also labeled as manufactured for CELIA Health.
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
US Nationwide.
Lot / Code Information
All lots within expiry.
Other Recalls from GenoGenix LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0081-2026 | Class II | Reconstitution XO Solution for Injection, all s... | Jul 30, 2025 |
| D-0054-2026 | Class II | Glycine for Injection, all strengths and presen... | Jul 30, 2025 |
| D-0051-2026 | Class II | GHK-Cu (Copper Peptide) for Injection, all stre... | Jul 30, 2025 |
| D-0062-2026 | Class II | Magnesium Chloride for Injection, all strengths... | Jul 30, 2025 |
| D-0071-2026 | Class II | Cerebrolysin for Injection, all strengths and p... | Jul 30, 2025 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.